Published in Arch Biochem Biophys on September 29, 2010
The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta (2011) 1.32
Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab (2013) 1.21
Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem (2012) 1.07
O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome. J Biol Chem (2012) 1.04
Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. Physiol Genomics (2012) 0.96
O-GlcNAc modification: why so intimately associated with phosphorylation? Cell Commun Signal (2011) 0.88
Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics. Genome Med (2013) 0.87
Discovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methods. PLoS One (2013) 0.85
Post-translational modifications of the cardiac proteome in diabetes and heart failure. Proteomics Clin Appl (2015) 0.81
Multiplexed Detection of O-GlcNAcome, Phosphoproteome, and Whole Proteome within the Same Gel. Front Endocrinol (Lausanne) (2014) 0.79
O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling. J Mol Biol (2016) 0.77
Aging leads to elevation of O-GlcNAcylation and disruption of mitochondrial homeostasis in retina. Oxid Med Cell Longev (2014) 0.76
Senescence-Associated Changes in Proteome and O-GlcNAcylation Pattern in Human Peritoneal Mesothelial Cells. Biomed Res Int (2015) 0.76
Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins. Biochem J (2016) 0.75
Mitochondrial O-GlcNAc transferase (mOGT) regulates mitochondrial structure, function and survival in HeLa cells. J Biol Chem (2017) 0.75
Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology (2006) 1.96
Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med (2008) 1.75
S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res (2009) 1.42
The role of prohibitin in cell signaling. FEBS J (2010) 1.21
Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J (2006) 1.05
Prohibitin is expressed in pancreatic beta-cells and protects against oxidative and proapoptotic effects of ethanol. FEBS J (2009) 0.99
Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Miner Res (2003) 0.99
Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling. Biochem Biophys Res Commun (2009) 0.95
Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLoS One (2009) 0.95
Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice. Endocrinology (2004) 0.94
Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1. Biochim Biophys Acta (2009) 0.92
Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide. J Ethnopharmacol (2012) 0.91
O-GlcNAc modification: why so intimately associated with phosphorylation? Cell Commun Signal (2011) 0.88
Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN. BMC Cancer (2012) 0.84
Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion. Endocrinology (2011) 0.83
Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2). Biochem Cell Biol (2010) 0.82
Overexpression of phospho mutant forms of transglutaminase 2 downregulates epidermal growth factor receptor. Biochem Biophys Res Commun (2011) 0.80
Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes. J Mol Endocrinol (2012) 0.77
Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance. Can J Physiol Pharmacol (2003) 0.77
Temporal analysis of protein lysine acetylation during adipocyte differentiation. Adipocyte (2013) 0.76
Glucose intolerance in aging male IGFBP-3 transgenic mice: differential effects of human IGFBP-3 and its mutant IGFBP-3 devoid of IGF binding ability. Endocrinology (2014) 0.76
Mutually exclusive acetylation and ubiquitylation among enzymes involved in glucose metabolism. Adipocyte (2013) 0.75
Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease. Curr Mol Pharmacol (2017) 0.75
Nuclear coded mitochondrial protein prohibitin is an iron regulated iron binding protein. Mitochondrion (2010) 0.75
Assessment of posttranslational modification of mitochondrial proteins. Methods Mol Biol (2015) 0.75